Page 6 - Calithera Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Calithera biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Calithera Biosciences Inc Today - Breaking & Trending Today

StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance CALA opened at $0.03 on Tuesday. The stock has a market capitalization of $146,100.00, a PE ratio of […] ....

United States , South San Francisco , Calithera Biosciences , Calithera Biosciences Inc , Vanguard Group Inc , Renaissance Technologies , Goldman Sachs Group Inc , Affinity Asset Advisors , Alyeska Investment Group , Free Report , Asset Advisors , Sachs Group , Vanguard Group , Get Free Report , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance NASDAQ:CALA opened at $0.03 on Monday. The company has a 50-day moving average price of $0.04 and a […] ....

South San Francisco , United States , Calithera Biosciences , Renaissance Technologies , Goldman Sachs Group Inc , Calithera Biosciences Company Profile , Vanguard Group Inc , Calithera Biosciences Inc , Alyeska Investment Group , Affinity Asset Advisors , Free Report , Asset Advisors , Goldman Sachs Group , Sachs Group , Get Free Report , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report report published on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Calithera Biosciences stock opened at $0.03 on Monday. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two […] ....

United States , South San Francisco , Calithera Biosciences , Alyeska Investment Group , Goldman Sachs Group Inc , Affinity Asset Advisors , Vanguard Group Inc , Calithera Biosciences Inc , Renaissance Technologies , Free Report , Asset Advisors , Goldman Sachs Group , Sachs Group , Get Free Report , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,

Kintara Therapeutics (NASDAQ:KTRA) & Calithera Biosciences (NASDAQ:CALA) Critical Contrast

Kintara Therapeutics (NASDAQ:KTRA) & Calithera Biosciences (NASDAQ:CALA) Critical Contrast
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , South San Francisco , Calithera Bioscience , Calithera Biosciences , Guangxi Wuzhou Pharmaceutical Group Co , Calithera Biosciences Inc , Delmar Pharmaceuticals Inc , Kintara Therapeutics Inc , Kintara Therapeutics , Get Free Report , Guangxi Wuzhou Pharmaceutical , Delmar Pharmaceuticals , Kintara Therapeutics Daily ,

Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance CALA opened at $0.03 on Monday. The stock has a market cap of $146,100.00, a PE ratio of […] ....

United States , South San Francisco , Calithera Biosciences , Goldman Sachs Group Inc , Vanguard Group Inc , Affinity Asset Advisors , Renaissance Technologies , Calithera Biosciences Inc , Alyeska Investment Group , Get Free Report , Sachs Group , Calithera Biosciences Daily , Nasdaq Cala , Initiated Coverage , Stocknews Com ,